Murray Stahl’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.75M | Sell |
18,887
-322
| -2% | -$69.3K | 0.05% | 72 |
|
|
2026
Q1 | $4.18M | Sell |
19,209
-332
| -2% | -$73.6K | 0.05% | 76 |
|
|
2025
Q4 | $4.46M | Sell |
19,541
-812
| -4% | -$185K | 0.06% | 72 |
|
|
2025
Q3 | $4.71M | Sell |
20,353
-3,357
| -14% | -$684K | 0.06% | 68 |
|
|
2025
Q2 | $4.4M | Sell |
23,710
-447
| -2% | -$83.1K | 0.05% | 77 |
|
|
2025
Q1 | $5.06M | Sell |
24,157
-1,891
| -7% | -$368K | 0.06% | 69 |
|
|
2024
Q4 | $4.63M | Buy |
26,048
+203
| +0.8% | +$37.3K | 0.06% | 74 |
|
|
2024
Q3 | $5.1M | Buy |
25,845
+1,722
| +7% | +$321K | 0.08% | 69 |
|
|
2024
Q2 | $4.14M | Buy |
24,123
+106
| +0.4% | +$17.6K | 0.07% | 71 |
|
|
2024
Q1 | $4.37M | Sell |
24,017
-23
| -0.1% | -$3.96K | 0.08% | 69 |
|
|
2023
Q4 | $3.73M | Sell |
24,040
-784
| -3% | -$114K | 0.08% | 71 |
|
|
2023
Q3 | $3.7M | Sell |
24,824
-25
| -0.1% | -$3.67K | 0.07% | 70 |
|
|
2023
Q2 | $3.35M | Sell |
24,849
-254
| -1% | -$37.2K | 0.07% | 75 |
|
|
2023
Q1 | $4M | Sell |
25,103
-2,184
| -8% | -$334K | 0.08% | 69 |
|
|
2022
Q4 | $4.41M | Hold |
27,287
| – | – | 0.07% | 68 |
|
|
2022
Q3 | $3.66M | Buy |
27,287
+264
| +1% | +$37.9K | 0.07% | 67 |
|
|
2022
Q2 | $4.14M | Sell |
27,023
-1,345
| -5% | -$206K | 0.09% | 68 |
|
|
2022
Q1 | $4.6M | Sell |
28,368
-200
| -0.7% | -$29.1K | 0.09% | 74 |
|
|
2021
Q4 | $3.87M | Hold |
28,568
| – | – | 0.09% | 77 |
|
|
2021
Q3 | $3.08M | Sell |
28,568
-500
| -2% | -$57.1K | 0.07% | 91 |
|
|
2021
Q2 | $3.27M | Buy |
29,068
+61
| +0.2% | +$6.87K | 0.07% | 91 |
|
|
2021
Q1 | $3.14M | Sell |
29,007
-1,226
| -4% | -$131K | 0.07% | 85 |
|
|
2020
Q4 | $3.24M | Sell |
30,233
-2,639
| -8% | -$254K | 0.11% | 75 |
|
|
2020
Q3 | $2.88M | Buy |
32,872
+761
| +2% | +$71.6K | 0.12% | 84 |
|
|
2020
Q2 | $3.15M | Sell |
32,111
-1,040
| -3% | -$91.6K | 0.11% | 75 |
|
|
2020
Q1 | $2.53M | Buy |
33,151
+1,867
| +6% | +$159K | 0.11% | 76 |
|
|
2019
Q4 | $2.77M | Buy |
31,284
+192
| +0.6% | +$15.9K | 0.08% | 82 |
|
|
2019
Q3 | $2.35M | Buy |
31,092
+431
| +1% | +$29.5K | 0.07% | 99 |
|
|
2019
Q2 | $2.23M | Buy |
30,661
+508
| +2% | +$39.9K | 0.06% | 108 |
|
|
2019
Q1 | $2.43M | Buy |
+30,153
| New | +$2.47M | 0.07% | 103 |
|
Other funds holding ABBV
Murray Stahl's ABBV Position: Q2 2026 in Review
Murray Stahl reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $69.3K and leaving 18,887 shares worth $4.75M. The position accounts for 0.05% of the portfolio, ranked #72.
Murray Stahl first reported a position in ABBV in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.1M in Q3 2024. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Murray Stahl held 18,887 shares of AbbVie worth $4.75M as of Q2 2026.
- Murray Stahl sold 322 AbbVie shares in Q2 2026, an estimated $69.3K.
- AbbVie made up 0.05% of Murray Stahl's portfolio in Q2 2026, its #72 holding.
- Murray Stahl first reported a position in AbbVie in Q1 2019 and has held it in 30 quarters since.
- Murray Stahl's AbbVie position peaked at $5.1M in Q3 2024.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.